Stockscreener 앱 받기
49.84
0.97%
0.48
시간 외 거래:
49.84
전일 마감가:
$49.36
열려 있는:
$49.83
하루 거래량:
278.89K
Relative Volume:
0.49
시가총액:
$2.15B
수익:
-
순이익/손실:
$-38.99M
주가수익비율:
-16.63
EPS:
-2.9966
순현금흐름:
$-24.94M
1주 성능:
+3.21%
1개월 성능:
+10.02%
6개월 성능:
+6.82%
1년 성능:
+8.00%
1일 변동 폭
$48.84
$51.49
1주일 범위
$45.94
$51.49
52주 변동 폭
$36.61
$60.92
Soleno Therapeutics Inc Stock (SLNO) Company Profile
명칭
Soleno Therapeutics Inc
전화
650-213-8444
주소
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
SLNO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
49.84 | 2.15B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 112.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 75.06B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.45B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.75B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 28.98B | 3.30B | -501.07M | 1.03B | -2.1146 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 재확인 | Robert W. Baird | Outperform |
| 2024-12-02 | 재확인 | Stifel | Buy |
| 2024-09-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-10 | 개시 | Robert W. Baird | Outperform |
| 2024-02-05 | 개시 | Piper Sandler | Overweight |
| 2024-01-23 | 개시 | Stifel | Buy |
| 2023-11-21 | 재개 | Guggenheim | Buy |
| 2020-09-29 | 개시 | Guggenheim | Buy |
| 2020-01-10 | 개시 | Craig Hallum | Buy |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2018-02-13 | 재확인 | Maxim Group | Buy |
모두보기
Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스
Soleno Therapeutics to Participate in Upcoming February Investor Conferences - The Manila Times
Rare Disease Pioneer Soleno Takes Center Stage at Major Healthcare Investment Forums - StockTitan
Moody Aldrich Partners LLC Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat
(SLNO) Investment Report - Stock Traders Daily
Soleno Therapeutics executives receive pay raises and bonuses - MSN
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lifted by JPMorgan Chase & Co. - Defense World
Soleno Therapeutics executives receive pay raises and bonuses By Investing.com - Investing.com Nigeria
Soleno Therapeutics Enhances Executive Compensation Structure - TipRanks
Brokers Set Expectations for SLNO FY2025 Earnings - Defense World
Equities Analysts Issue Forecasts for SLNO FY2025 Earnings - MarketBeat
High Growth Tech Stocks to Watch in January 2025 - Simply Wall St
Soleno Therapeutics Breaks Above 200-Day Moving AverageBullish for SLNO - Nasdaq
Soleno Therapeutics (NASDAQ:SLNO) Trading 8.6% HigherHere's What Happened - MarketBeat
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $74.83 Consensus PT from Brokerages - MarketBeat
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of “Buy” by Brokerages - Defense World
Is Soleno Therapeutics (SLNO) the Top Small Cap Stock to Buy with the Highest Upside Potential? - MSN
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential - Insider Monkey
Analysts Predict How High Soleno Therapeutics Inc (SLNO) Will Go. - Stocks Register
Have Insiders Sold Soleno Therapeutics Shares Recently? - Simply Wall St
Trading (SLNO) With Integrated Risk Controls - Stock Traders Daily
Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven? - Yahoo Finance
Soleno Therapeutics senior VP Patricia Hirano sells $138,709 in stock By Investing.com - Investing.com Australia
Soleno therapeutics' SVP Kristen Yen sells $222,483 in stock By Investing.com - Investing.com Australia
Soleno Therapeutics CFO James Mackaness sells $360,460 in stock By Investing.com - Investing.com South Africa
Soleno Therapeutics CFO James Mackaness sells $360,460 in stock - Investing.com India
Soleno Therapeutics CEO sells $965,515 in stock - Investing.com India
Soleno therapeutics’ SVP Kristen Yen sells $222,483 in stock By Investing.com - Investing.com Nigeria
Soleno Therapeutics CEO sells $965,515 in stock By Investing.com - Investing.com South Africa
Insider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Sells 10,937 Shares of Stock - MarketBeat
Insider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) CFO Sells 4,083 Shares of Stock - MarketBeat
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells $108,061.20 in Stock - MarketBeat
Soleno Therapeutics senior VP Patricia Hirano sells $138,709 in stock - Investing.com India
Soleno therapeutics' SVP Kristen Yen sells $222,483 in stock - Investing.com India
Soleno Therapeutics (NASDAQ:SLNO) Trading Down 2.5%Time to Sell? - MarketBeat
Soleno Therapeutics, Inc.'s (NASDAQ:SLNO) Path To Profitability - Simply Wall St
Investors Buy Large Volume of Soleno Therapeutics Put Options (NASDAQ:SLNO) - Defense World
Soleno Therapeutics Target of Unusually High Options Trading (NASDAQ:SLNO) - MarketBeat
(SLNO) Long Term Investment Analysis - Stock Traders Daily
Geode Capital Management LLC Buys 51,189 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Increased by Geode Capital Management LLC - MarketBeat
Barclays PLC Increases Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Barclays PLC Acquires 31,467 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Soleno Therapeutics is Now Oversold (SLNO) - Nasdaq
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.11 Million Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno Therapeutics Inc (SLNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.49%
0.79%
자본화:
|
볼륨(24시간):